Table I.
Clinical features of the patients recruited in the present study.
| Immunohistochemistry results | |||
|---|---|---|---|
| Clinical feature | Liver | Pancreatic | Liver TCGA dataset |
| Total no. of cancer cases | 178 | 91 | 134 |
| Gender (n) | |||
| Male | 120 | 56 | 80 |
| Female | 58 | 35 | 54 |
| Age (n) | |||
| <60 | 124 | 71 | 67 |
| ≥60 | 54 | 20 | 67 |
| Mean age (years) | 53.41±11.11 | 52.70±9.96 | 62.10±13.34 |
| Pathological grade (n) | |||
| ≤2 | 77 | 51 | – |
| >2 | 89 | 15 | – |
| Clinical stage (n) | |||
| I/II | 80 | 84 | – |
| III/IV | 98 | 6 | – |
| I | – | – | 50 |
| II–IV | – | – | 75 |
| pT stage (n) | |||
| T1-T2 | 91 | 34 | 53 |
| T3-T4 | 86 | 56 | 81 |
| pN stage (n) | |||
| N0 | 144 | 78 | 83 |
| N1/N2 | 33 | 12 | 3 |
| Metastasis (n) | 3 | 2 | 3 |
| Benign (n) | 7 | 5 | 0 |
‘−’ indicates a lack of the relative information for these patients. Of the 134 patients in the TCGA dataset, 9 had no information regarding clinical stage. TCGA, The Cancer Genome Atlas; pT stage, primary tumor stage; pN stage, regional lymph node stage.